Top 20 of Leishmaniasis, Visceral

Article title # Publications/# Citations

Leishmaniasis: current situation and new perspectives.

2004: PDesjeux;

248

Leishmaniasis.

1999: BLHerwaldt;

189

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

2007: JAlvar; MBoelaert; FChappuis; HGhalib; AHailu; RWPeeling; SRijal; SSundar;

159

Comparative genomic analysis of three Leishmania species that cause diverse human disease.

2007: EAdlem; CArrowsmith; MAslett; SLBaldauf; BBarrell; MBerriman; FBringaud; LOBrito; ... TCarver; TChillingworth; AKCruz; DPDepledge; AFaulconbridge; AFraser; ZHance; DHarris; JDHilley; AIvens; KJagels; DJeffares; AKerhornou; JCMottram; SMoule; LMurphy; HNorbertczak; DOrmond; SOOyola; CSPeacock; NPeters; MAQuail; ERabbinowitsch; MARajandream; JCRuiz; SRutter; KSeeger; DFSmith; RSquares; SThurston; ATivey; LRTosi; BWhite; SWhitehead;

146

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.

1995: SGauthier; GGovoni; PGros; SJothy; DMalo; MOlivier; GSebastiani; ESkamene; MLTremblay; SVidal;

114

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

1983: HWMurray; CDRothermel; BYRubin;

109

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

2002: MBoelaert; ADBryceson; SLCroft; PDesjeux; PJGuerin; POlliaro; SSundar; MKWasunna;

105

Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

1993: AMEl-Hassan; HWGhalib; FAHashim; MRPiuvezam; SGReed; DMRusso; MSiddig; YASkeiky;

100

The increase in risk factors for leishmaniasis worldwide.

2001 May-Jun: PDesjeux;

97

Immunological phenomena in leprosy and related diseases.

1971: ADBryceson; JLTurk;

90

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.

1999: HWMurray; CFNathan;

85

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

1993: SHEl-Safi; MHag-Ali; FAHashim; CLKarp; AMKordofani; FANeva; TBNutman; DLSacks; MMSatti; TAWynn;

84

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.

2000: PCKumar; AMakharia; DKMore; HWMurray; SSharma; MKSingh; VPSingh; SSundar;

83

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

1985: RBadaró; EMCarvalho; WDJohnson; TCJones; SGReed;

80

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.

1993: RBadaró; DRBenson; JMBurns; HWGhalib; SGReed; WGShreffler;

80

Oral miltefosine for Indian visceral leishmaniasis.

2002: JBerman; ABryceson; JEngel; CFischer; TKJha; KJunge; HSindermann; SSundar; CPThakur;

80

Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.

2007: LEidsmo; KDManandhar; RMaurya; SNylén; DSacks; SSundar;

77

Leishmaniasis. Public health aspects and control.

1996 Sep-Oct: PDesjeux;

72

Leishmaniasis and poverty.

2006: JAlvar; CBern; SYactayo;

71

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

2003: GHCoombs; SLCroft;

69